MEDICAL ONCOLOGY · MEMORIAL GÖZTEPE
Doç. Dr. Tuğba Başoğlu Tüylü
Associate Professor of Medical Oncology · Memorial Göztepe Hospital
Tuğba Başoğlu Tüylü is a medical oncologist at Memorial Göztepe Hospital's oncology centre, where she has worked since 2025. She trained in internal medicine at Dokuz Eylül University Faculty of Medicine and completed her medical oncology fellowship at Marmara University Faculty of Medicine in 2021. She then practised at Niğde Ömer Halisdemir Training and Research Hospital and, from 2023 to 2025, at Kartal Dr. Lütfi Kırdar City Hospital. The Turkish Society of Medical Oncology listed her among members newly granted the associate professor title. Her published research covers gastrointestinal, breast and thoracic tumours, with a particular focus on laboratory and imaging-derived prognostic indices, and she is a member of ESMO and ASCO.
Specialties:
Oncology
Medical oncologyGastrointestinal cancers (gastric, gastroesophageal junction, pancreatic)Breast cancer and neoadjuvant chemotherapyLung cancer and thoracic tumoursGenitourinary cancers, including renal cell carcinoma and prostate cancerRare tumours (chordoma, epithelioid hemangioendothelioma, inflammatory myofibroblastic tumour)
A BergemHealth coordinator arranges contact with the professor within 24–48 hours on business days.
Direct contract with BergemHealth
CONSULTATION LANGUAGES
Turkish
English
ISTANBUL · 08/2026
EDUCATION & CAREER
Timeline
2009-2013
Internal medicine residency, Dokuz Eylül University Faculty of Medicine, İzmir
2018-2021
Medical oncology fellowship, Marmara University Faculty of Medicine, Pendik Training and Research Hospital
2021-2023
Medical oncologist, Niğde Ömer Halisdemir Training and Research Hospital
2023-2025
Medical oncologist, Kartal Dr. Lütfi Kırdar City Hospital, Istanbul
2025-present
Medical oncologist, Memorial Göztepe Hospital Oncology Centre, Istanbul
PUBLICATIONS
Scientific work
-
2023Indian Journal of Cancer, vol. 60(2), pp. 179-184«Prognostic value of the Gustave Roussy immune score in operable pancreatic adenocarcinoma»
-
2020World Journal of Surgical Oncology, vol. 18(1), 242«Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment?»
-
2024Scientific Reports, vol. 14(1), 12123«The role of laboratory indices on treatment response and survival in breast cancer receiving neoadjuvant chemotherapy»
-
2020Current Problems in Cancer, vol. 44(5), 100568«VEGF-VEGFR pathway seems to be the best target in hepatic epithelioid hemangioendothelioma: a case series with review of the literature»
-
2024Medicina, vol. 60(8), 1374«Prognostic impact and clinical features of spread through air spaces in operated lung cancer: real-world analysis»
CLINIC
Where they practise
Direct contract with BergemHealth at every listed clinic.
REQUEST
Tell me about your case — I’ll read it personally.
Fill in the short form on the consultation page — diagnosis, preferred timing, attached records. We assemble a tumour board for your case and reply within 4 hours.
Open the consultation form- Reply within 4 hours during business hours
- Confidentiality guaranteed
- Coordinator-translator inside the doctor’s office
- Tumour board of 2–3 professors within 72 hours
OTHER DOCTORS
Similar BergemHealth professors
Adjacent specialties and second opinions. Direct contracts, verified cases.